Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo ‐controlled crossover study
Movement Disorders, EarlyView.
Source: Movement Disorders - Category: Neurology Authors: Donald L.
Gilbert
MD
,
Tanya K.
Murphy
,
Joseph
Jankovic
MD
,
Cathy L.
Budman
MD
,
Kevin J.
Black
MD
,
Roger M.
Kurlan
MD
,
Keith A.
Coffman
MD
,
James T.
McCracken
MD
,
Jorge
Juncos
MD
,
Jon E.
Grant
MD
,
Richard Source Type: research